Coronavirus: BioNTech says mutation-beating vaccine can be ready in six weeks

The co-founder of BioNTech said Tuesday it was “highly likely” that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks.

For more coronavirus news, visit our dedicated page.

“Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant,” said Ugur Sahin.

But if needed, “in principle the beauty of the messenger technology is that we can directly start to engineer a vaccine which completely mimics this new mutation – we could be able to provide a new vaccine technically within six weeks.”

Also read: The new coronavirus variant in Britain: Everything we know so far

Read more:

New strain of coronavirus not detected in Saudi Arabia ‘yet’: Health ministry

'No hard evidence' new UK coronavirus variant is more contagious: US official

Coronavirus vaccine volunteers not showing any side effects: Saudi Arabia’s ministry